Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.9K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vitro Analysis of Cytotoxic Activities of <i>Monotheca buxifolia</i> Targeting <i>WNT</i>/<i>β-Catenin</i> Genes in Breast Cancer Cells.

Plants (Basel, Switzerland)·2023
Same author

Role of Polyamine-Induced Dimerization of Antizyme in Its Cellular Functions.

International journal of molecular sciences·2022
Same author

Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.

Biomolecules·2021
Same author

Repurposing of idebenone as a potential anti-cancer agent.

The Biochemical journal·2019

Related Experiment Video

Updated: Aug 28, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K

Understanding the Polyamine and mTOR Pathway Interaction in Breast Cancer Cell Growth.

Oluwaseun Akinyele1,2, Heather M Wallace1

  • 1Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.

Medical Sciences (Basel, Switzerland)
|September 22, 2022
PubMed
Summary

Polyamines, crucial for cell growth, interact with the mTOR pathway in breast cancer. Inhibiting both polyamine synthesis and mTOR may offer new therapeutic strategies for cancer treatment.

Keywords:
4E-BP1growthmTOR pathwayp70SK1 and translation initiationphosphorylationpolyamines

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

232
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.3K

Related Experiment Videos

Last Updated: Aug 28, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

232
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Polyamines (putrescine, spermidine, spermine) are polycationic molecules vital for cell growth and implicated in cancer.
  • The PI3K/Akt and mTOR signaling pathways are critical for cell growth and frequently dysregulated in breast cancer.
  • Polyamines are known to mediate downstream effects of the PI3K/Akt pathway, influencing mTOR signaling.

Purpose of the Study:

  • To investigate the impact of modulating intracellular polyamines on mTORC1 signaling and protein translation in breast cancer cells.
  • To assess the effects of inhibiting the mTORC1 pathway on cell growth and polyamine levels.
  • To explore the combined effects of inhibiting polyamine biosynthesis and the mTORC1 pathway.

Main Methods:

  • Utilized two breast cancer cell lines (MCF-7 and MDA-MB-231) for experiments.
  • Modulated intracellular polyamine levels and inhibited the mTORC1 pathway using siRNA.
  • Measured protein phosphorylation (4EBP1, p70S6K), general translation, cell growth, and intracellular polyamine content.

Main Results:

  • Polyamines significantly altered 4EBP1 and p70S6K phosphorylation, impacting translation initiation in breast cancer cells.
  • mTOR inhibition via siRNA reduced cell proliferation and decreased putrescine and spermidine levels.
  • Combined inhibition of polyamine biosynthesis and mTORC1 resulted in enhanced cytotoxicity and translation inhibition.

Conclusions:

  • Polyamines contribute to breast cancer cell growth, partly via interaction with the mTOR pathway.
  • Intracellular polyamine content is closely linked to the regulation of the mTOR pathway.
  • Dual inhibition of polyamine and mTOR pathways presents a potential therapeutic strategy for certain breast cancers.